siRNA, Anti-Human ACP5, LNA(CAT#: SIRGT04038WQ-LNA)

The product SIRGT04038WQ-LNA is a type of small interfering RNA (siRNA) that targets ACP5 gene and regulates the expression of gene. The siRNA interferes with the expression of ACP5 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001111034.2; NM_001111035.2; NM_001111036.2; NM_001322023.1; NM_001611.4
Alternative Names HPAP; TRACP5a; TRACP5b; TRAP; TrATPase
Related Diseases Spondyloenchondrodysplasia With Immune Dysregulation, Spondyloenchondrodysplasia
Purification HPLC
Target Gene
Gene ID 54
Uniprot ID P13686

Related Products